Skip to main content
ChoA Pharmaceutical Co., LTD. logo

ChoA Pharmaceutical Co., LTD. — Investor Relations & Filings

Ticker · 034940 ISIN · KR7034940007 KO Manufacturing
Open in API
Filings indexed 115 across all filing types
Latest filing 2026-03-23 Declaration of Voting R…
Country KR South Korea
Listing KO 034940

About ChoA Pharmaceutical Co., LTD.

https://www.choa.co.kr/en/

ChoA Pharmaceutical Co., LTD., established in 1988, is a company engaged in the development, manufacturing, and sale of pharmaceutical products and health supplements. The company's portfolio comprises approximately 200 products, including over-the-counter (OTC) drugs, generic medications, and functional health foods. It offers a diverse range of formulations such as tablets, capsules, granules, ampoules, and a notable selection of liquid and drinkable products. ChoA Pharmaceutical primarily supplies pharmacies and maintains a global business presence, exporting its products to more than 20 countries. The company focuses on developing high-quality medicines and health-related products to contribute to public well-being.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled “정기주주총회결과” (Annual General Meeting Results) and provides detailed voting outcomes for each agenda item, including approval rates, director elections, and constitutional amendments. This is a clear announcement of shareholder vote results at a general meeting, which corresponds to Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-03-23 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Audit Report' (감사보고서) for JoongAng Pharmaceutical Co., Ltd. It includes the independent auditor's report, financial statements (balance sheet, income statement, cash flow, etc.), and detailed notes. It is not an Annual Report (10-K) as it focuses specifically on the audit and financial statements rather than the broader company activity report, and it is not an announcement (RPA) because it contains the full financial data. FY 2025
2026-03-13 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by Cho-A Pharm. It contains the auditor's opinion (적정 - Unqualified), financial statements (consolidated and separate), and key financial metrics required by regulatory standards. While it provides financial data, it is a specific regulatory filing regarding the submission of the audit report itself, which falls under the category of Audit Report / Information. FY 2025
2026-03-13 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Cho-A Pharm. Co., Ltd. It contains the meeting agenda, details on voting procedures, and management's report on business activities and financial statements (balance sheet, income statement, etc.) for the 30th fiscal year. While it includes financial data, this is standard content for a proxy statement/notice of meeting sent to shareholders to solicit votes for the upcoming AGM. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2026-02-25 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (Proxy Solicitation & Information Statement). It contains detailed information regarding the upcoming Annual General Meeting (AGM), including the agenda, voting procedures, and financial statements (balance sheets and income statements) provided as supporting information for shareholders to make informed voting decisions. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2026-02-25 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Cho-A Pharm. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2026-02-19 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.